Copyright © 2024 National Products Inc. Seattle, Washington. All rights reserved.
Company: National Products Inc.
Address: 8410 Dallas Ave S.
Seattle, Wa. 98108
Contact person: Chad Remmers
Title: COO
E-mail: chad.remmers@rammount.com Telephone: 206-763-8361
P/N: All Products Produced
This letter is to assure that the above-mentioned product(s) made from the above-mentioned company do not contain any of the following California Proposition 65 chemicals, or if a threshold is stated, then all before mentioned parts are below the required levels.
Chemical | Type of Toxicity | Listing Mechanism | CAS No. | Date Listed | NSRL or MADL (µg/day)a |
A-alpha-C (2-Amino-9H-pyrido[2,3-b]indole) | cancer | AB | 26148-68-5 | 1-Jan-90 | 2 |
Acetaldehyde | cancer | SQE | 75-07-0 | 1-Apr-88 | 90 (inhalation) |
Acetamide | cancer | AB | 60-35-5 | 1-Jan-90 | 10 |
Acetazolamide | developmental | FR | 59-66-5 | 20-Aug-99 | |
Acetochlor | cancer | SQE | 34256-82-1 | 1-Jan-89 | |
Acetohydroxamic acid | developmental | FR | 546-88-3 | 1-Apr-90 | |
2-Acetylaminofluorene | cancer | SQE | 53-96-3 | 1-Jul-87 | 0.2 |
Acifluorfen sodium | cancer | AB | 62476-59-9 | 1-Jan-90 | |
Acrylamide | cancer | AB | 79-06-1 | 1-Jan-90 | 0.2 |
Acrylamide | developmental, male | AB | 79-06-1 | 25-Feb-11 | 140 |
Acrylonitrile | cancer | FR | 107-13-1 | 1-Jul-87 | 0.7 |
Actinomycin D [Basis for listing changed effective February 22, 2013] | cancer | FR | 50-76-0 | 1-Oct-89 | 0.00008 |
Actinomycin D | developmental | FR | 50-76-0 | 1-Oct-92 | |
AF-2;[2-(2-furyl)-3-(5-nitro-2-furyl)]acrylamide | cancer | SQE | 3688-53-7 | 1-Jul-87 | 3 |
Aflatoxins | cancer | SQE | --- | 1-Jan-88 | |
Alachlor | cancer | SQE | 15972-60-8 | 1-Jan-89 | |
Alcoholic beverages, when associated with alcohol abuse | cancer | SQE | --- | 1-Jul-88 | |
Aldrin | cancer | SQE | 309-00-2 | 1-Jul-88 | 0.04 |
All-trans retinoic acid | developmental | SQE | 302-79-4 | 1-Jan-89 | |
Allyl chloride Delisted October 29, 1999 [Click here for the basis for delisting] | |||||
Alprazolam | developmental | FR | 28981-97-7 | 1-Jul-90 | |
Altretamine | developmental, male | FR | 645-05-6 | 20-Aug-99 | |
Amantadine hydrochloride | developmental | FR | 665-66-7 | 27-Feb-01 | |
Amikacin sulfate | developmental | FR | 39831-55-5 | 1-Jul-90 | |
2-Aminoanthraquinone | cancer | LC | 117-79-3 | 1-Oct-89 | 20 |
p-Aminoazobenzene | cancer | AB | 60-09-3 | 1-Jan-90 | |
o-Aminoazotoluene | cancer | SQE | 97-56-3 | 1-Jul-87 | 0.2 |
4-Aminobiphenyl (4-aminodiphenyl) | cancer | LC | 92-67-1 | 27-Feb-87 | 0.03 |
1-Amino-2,4-dibromoanthraquinone | cancer | AB | 81-49-2 | 26-Aug-97 | |
3-Amino-9-ethylcarbazole hydrochloride | cancer | SQE | 6109-97-3 | 1-Jul-89 | 9 |
2-Aminofluorene | cancer | SQE | 153-78-6 | 29-Jan-99 | |
Aminoglutethimide | developmental | FR | 125-84-8 | 1-Jul-90 | |
Aminoglycosides | developmental | FR | --- | 1-Oct-92 | |
1-Amino-2-methylanthraquinone | cancer | LC | 82-28-0 | 1-Oct-89 | 5 |
2-Amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazole | cancer | SQE | 712-68-5 | 1-Jul-87 | 0.04 |
4-Amino-2-nitrophenol | cancer | SQE | 119-34-6 | 29-Jan-99 | |
Aminopterin | developmental, female | SQE | 54-62-6 | 1-Jul-87 | |
Amiodarone hydrochloride | developmental, female, male | FR | 19774-82-4 | 26-Aug-97 | |
Amitraz | developmental | AB | 33089-61-1 | 30-Mar-99 | |
Amitrole | cancer | SQE | 61-82-5 | 1-Jul-87 | 0.7 |
Amoxapine | developmental | FR | 14028-44-5 | 15-May-98 | |
Amsacrine | cancer | LC | 51264-14-3 | 7-Aug-09 | |
tert-Amyl methyl ether Delisted December 13, 2013 [Click here for the basis for delisting] | |||||
Anabolic steroids | female, male | FR | --- | 1-Apr-90 | |
Analgesic mixtures containing Phenacetin | cancer | LC | --- | 27-Feb-87 | |
Androstenedione | cancer | AB | 63-05-8 | 3-May-11 | |
Angiotensin converting enzyme (ACE) inhibitors | developmental | FR | --- | 1-Oct-92 | |
Aniline | cancer | AB | 62-53-3 | 1-Jan-90 | 100 |
Aniline hydrochloride | cancer | AB | 142-04-1 | 15-May-98 | |
o-Anisidine | cancer | SQE | 90-04-0 | 1-Jul-87 | 5 |
o-Anisidine hydrochloride | cancer | SQE | 134-29-2 | 1-Jul-87 | 7 |
Anisindione | developmental | FR | 117-37-3 | 1-Oct-92 | |
Anthraquinone | cancer | AB | 84-65-1 | 28-Sep-07 | |
Antimony oxide (Antimony trioxide) | cancer | AB | 1309-64-4 | 1-Oct-90 | |
Aramite | cancer | SQE | 140-57-8 | 1-Jul-87 | 20 |
Areca nut | cancer | LC | --- | 3-Feb-06 | |
Aristolochic acids | cancer | LC | --- | 9-Jul-04 | |
Arsenic (inorganic arsenic compounds) | cancer | LC | -- | 27-Feb-87 | 0.06 (inhalation) 10 (except inhalation) |
Arsenic (inorganic oxides) | developmental | SQE | --- | 1-May-97 | |
Asbestos | cancer | LC | 1332-21-4 | 27-Feb-87 | 100 fibers/day (inhalation) |
Aspirin (NOTE: It is especially important not to use aspirin during the last three months of pregnancy, unless specifically directed to do so by a physician because it may cause problems in the unborn child or complications during delivery.) | developmental, female | SQE | 50-78-2 | 1-Jul-90 | |
Atenolol | developmental | FR | 29122-68-7 | 26-Aug-97 | |
Auramine | cancer | SQE | 492-80-8 | 1-Jul-87 | 0.8 |
Auranofin | developmental | FR | 34031-32-8 | 29-Jan-99 | |
Avermectin B1 (Abamectin) | developmental | AB | 71751-41-2 | 3-Dec-10 | 4.4 |
Azacitidine | cancer | AB | 320-67-2 | 1-Jan-92 | |
Azaserine | cancer | SQE | 115-02-6 | 1-Jul-87 | 0.06 |
Azathioprine | cancer | LC | 446-86-6 | 27-Feb-87 | 0.4 |
Azathioprine | developmental | FR | 446-86-6 | 1-Sep-96 | |
Azobenzene | cancer | AB | 103-33-3 | 1-Jan-90 | 6 |
Barbiturates | developmental | FR | --- | 1-Oct-92 | |
Beclomethasone dipropionate | developmental | FR | 5534-09-8 | 15-May-98 | |
Benomyl | developmental, male | SQE | 17804-35-2 | 1-Jul-91 | |
Benthiavalicarb-isopropyl | cancer | AB | 177406-68-7 | 1-Jul-08 | |
Benz[a]anthracene | cancer | SQE | 56-55-3 | 1-Jul-87 | 0.033 (oral) |
Benzene | cancer | LC | 71-43-2 | 27-Feb-87 | 6.4 (oral) 13 (inhalation) |
Benzene | developmental, male | SQE | 71-43-2 | 26-Dec-97 | 24 (oral) 49 (inhalation) |
Benzidine [and its salts] | cancer | LC | 92-87-5 | 27-Feb-87 | 0.001 |
Benzidine-based dyes | cancer | FR | --- | 1-Oct-92 | |
Benzodiazepines | developmental | FR | --- | 1-Oct-92 | |
Benzo[b]fluoranthene | cancer | SQE | 205-99-2 | 1-Jul-87 | 0.096 (oral) |
Benzo[j]fluoranthene | cancer | SQE | 205-82-3 | 1-Jul-87 | 0.11 (oral) |
Benzo[k]fluoranthene | cancer | SQE | 207-08-9 | 1-Jul-87 | |
Benzofuran | cancer | AB | 271-89-6 | 1-Oct-90 | 1.1 |
Benzophenone | cancer | LC | 119-61-9 | 22-Jun-12 | |
Benzo[a]pyrene | cancer | SQE | 50-32-8 | 1-Jul-87 | 0.06 |
Benzotrichloride | cancer | SQE | 98-07-7 | 1-Jul-87 | |
Benzphetamine hydrochloride | developmental | FR | 5411-22-3 | 1-Apr-90 | |
Benzyl chloride | cancer | AB | 100-44-7 | 1-Jan-90 | 4 |
Benzyl violet 4B | cancer | SQE | 1694-09-3 | 1-Jul-87 | 30 |
Beryllium and beryllium compounds | cancer | SQE | --- | 1-Oct-87 | |
Beryllium | 0.1 | ||||
Beryllium oxide | 0.1 | ||||
Beryllium sulfate | 0.0002 | ||||
Betel quid with tobacco | cancer | AB | --- | 1-Jan-90 | |
Betel quid without tobacco | cancer | LC | --- | 3-Feb-06 | |
2,2-Bis(bromomethyl)-1,3-propanediol | cancer | AB | 3296-90-0 | 1-May-96 | |
Bis(2-chloroethyl)ether | cancer | SQE | 111-44-4 | 1-Apr-88 | 0.3 |
N,N-Bis(2-chloroethyl)-2-naphthylamine (Chlornapazine) | cancer | LC | 494-03-1 | 27-Feb-87 | |
Bischloroethyl nitrosourea (BCNU) (Carmustine) | cancer | SQE | 154-93-8 | 1-Jul-87 | |
Bischloroethyl nitrosourea (BCNU) (Carmustine) | developmental | FR | 154-93-8 | 1-Jul-90 | |
Bis(chloromethyl)ether | cancer | LC | 542-88-1 | 27-Feb-87 | 0.02 |
Bis(2-chloro-1-methylethyl)ether, technical grade | cancer | SQE | --- | 29-Oct-99 | |
Bisphenol A (BPA) Delisted April 19, 2013 [Click here for the basis for delisting] | |||||
Bitumens, extracts of steam-refined and air refined | cancer | AB | --- | 1-Jan-90 | |
Bracken fern | cancer | AB | --- | 1-Jan-90 | |
Bromacil lithium salt | developmental | AB | 53404-19-6 | 18-May-99 | |
Bromacil lithium salt | male | SQE | 53404-19-6 | 17-Jan-03 | |
Bromate | cancer | AB | 15541-45-4 | 31-May-02 | |
Bromochloroacetic acid | cancer | AB | 5589-96-8 | 6-Apr-10 | |
Bromodichloromethane | cancer | AB | 75-27-4 | 1-Jan-90 | 5 |
Bromoethane | cancer | AB | 74-96-4 | 22-Dec-00 | 96 |
Bromoform | cancer | AB | 75-25-2 | 1-Apr-91 | 64 |
1-Bromopropane (1-BP) | developmental, female, male | AB | 106-94-5 | 7-Dec-04 | |
2-Bromopropane (2-BP) | female, male | AB | 75-26-3 | 31-May-05 | |
Bromoxynil | developmental | FR | 1689-84-5 | 1-Oct-90 | |
Bromoxynil octanoate | developmental | AB | 1689-99-2 | 18-May-99 | |
Butabarbital sodium | developmental | FR | 143-81-7 | 1-Oct-92 | |
1,3-Butadiene | cancer | SQE | 106-99-0 | 1-Apr-88 | 0.4 |
1,3-Butadiene | developmental, female, male | AB | 106-99-0 | 16-Apr-04 | |
1,4-Butanediol dimethanesulfonate (Busulfan) | cancer | LC | 55-98-1 | 27-Feb-87 | |
1,4-Butanediol dimethanesulfonate (Busulfan) | developmental | SQE | 55-98-1 | 1-Jan-89 | |
Butylated hydroxyanisole | cancer | AB | 25013-16-5 | 1-Jan-90 | 4000 |
Butyl benzyl phthalate (BBP)d | developmental | AB | 85-68-7 | 2-Dec-05 | 1200 (oral) |
n-Butyl glycidyl ether Delisted April 4, 2014 [Click here for the basis for delisting] | |||||
beta-Butyrolactone | cancer | SQE | 3068-88-0 | 1-Jul-87 | 0.7 |
Cacodylic acid | cancer | AB | 75-60-5 | 1-May-96 | |
Cadmium | developmental, male | SQE | --- | 1-May-97 | 4.1 (oral) |
Cadmium and cadmium compounds | cancer | SQE | --- | 1-Oct-87 | |
Cadmium | 0.05 (inhalation) | ||||
Caffeic acid | cancer | AB | 331-39-5 | 1-Oct-94 | |
Captafol | cancer | SQE | 2425-06-1 | 1-Oct-88 | 5 |
Captan | cancer | AB | 133-06-2 | 1-Jan-90 | 300 |
Carbamazepine | developmental | FR | 298-46-4 | 29-Jan-99 | |
Carbaryl | cancer | AB | 63-25-2 | 5-Feb-10 | |
Carbaryl [Basis for listing changed effective December 27, 2013] | developmental, female, male | AB | 63-25-2 | 7-Aug-09 | |
Carbazole | cancer | AB | 86-74-8 | 1-May-96 | 4.1 |
Carbon black (airborne, unbound particles of respirable size) | cancer | AB | 1333-86-4 | 21-Feb-03 | |
Carbon disulfide | developmental, female, male | SQE | 75-15-0 | 1-Jul-89 | |
Carbon monoxide | developmental | SQE | 630-08-0 | 1-Jul-89 | |
Carbon tetrachloride | cancer | SQE | 56-23-5 | 1-Oct-87 | 5 |
Carbon-black extracts | cancer | AB | --- | 1-Jan-90 | |
Carboplatin | developmental | FR | 41575-94-4 | 1-Jul-90 | |
N-Carboxymethyl-N-nitrosourea | cancer | SQE | 60391-92-6 | 25-Jan-02 | 0.7 |
Catechol | cancer | AB | 120-80-9 | 15-Jul-03 | |
Ceramic fibers (airborne particles of respirable size) | cancer | AB | --- | 1-Jul-90 | |
Certain combined chemotherapy for lymphomas | cancer | LC | --- | 27-Feb-87 | |
Chenodiol | developmental | FR | 474-25-9 | 1-Apr-90 | |
Chloral | cancer | LC | 75-87-6 | 13-Sep-13 | |
Chloral hydrate | cancer | LC | 302-17-0 | 13-Sep-13 | |
Chlorambucil | cancer | LC | 305-03-3 | 27-Feb-87 | 0.002 |
Chlorambucil | developmental | SQE | 305-03-3 | 1-Jan-89 | |
Chloramphenicol Delisted January 4, 2013 [Click here for the basis for delisting] | |||||
Chloramphenicol sodium succinate | cancer | FR | 982-57-0 | 27-Sep-13 | |
Chlorcyclizine hydrochloride | developmental | FR | 1620-21-9 | 1-Jul-87 | |
Chlordane | cancer | SQE | 57-74-9 | 1-Jul-88 | 0.5 |
Chlordecone (Kepone) | cancer | SQE | 143-50-0 | 1-Jan-88 | 0.04 |
Chlordecone (Kepone) | developmental | SQE | 143-50-0 | 1-Jan-89 | |
Chlordiazepoxide | developmental | FR | 58-25-3 | 1-Jan-92 | |
Chlordiazepoxide hydrochloride | developmental | FR | 438-41-5 | 1-Jan-92 | |
Chlordimeform | cancer | SQE | 6164-98-3 | 1-Jan-89 | |
Chlorendic acid | cancer | SQE | 115-28-6 | 1-Jul-89 | 8 |
Chlorinated paraffins (Average chain length, C12;approximately 60 percent chlorine by weight) | cancer | SQE | 108171-26-2 | 1-Jul-89 | 8 |
p-Chloroaniline | cancer | AB | 106-47-8 | 1-Oct-94 | 1.5 |
p-Chloroaniline hydrochloride | cancer | AB | 20265-96-7 | 15-May-98 | 1.9 |
Chlorodibromomethane Delisted October 29, 1999 [Click here for the basis for delisting] | |||||
Chloroethane (Ethyl chloride) | cancer | AB | 75-00-3 | 1-Jul-90 | 150 |
1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) (Lomustine) | cancer | SQE | 13010-47-4 | 1-Jan-88 | |
1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) (Lomustine) | developmental | FR | 13010-47-4 | 1-Jul-90 | |
1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea (Methyl-CCNU) | cancer | SQE | 13909-09-6 | 1-Oct-88 | |
Chloroform | cancer | SQE | 67-66-3 | 1-Oct-87 | 20 (oral) 40 (inhalation) |
Chloroform | developmental | LC | 67-66-3 | 7-Aug-09 | |
Chloromethyl methyl ether (technical grade) | cancer | LC | 107-30-2 | 27-Feb-87 | 0.3 |
3-Chloro-2-methylpropene | cancer | SQE | 563-47-3 | 1-Jul-89 | 5 |
1-Chloro-4-nitrobenzene | cancer | SQE | 100-00-5 | 29-Oct-99 | |
4-Chloro-o-phenylenediamine | cancer | SQE | 95-83-0 | 1-Jan-88 | 40 |
Chloroprene | cancer | AB | 126-99-8 | 2-Jun-00 | |
2-Chloropropionic acid [Basis for listing changed effective December 20, 2013] | male | SQE | 598-78-7 | 7-Aug-09 | |
Chlorothalonil | cancer | SQE | 1897-45-6 | 1-Jan-89 | 41 |
p-Chloro-o-toluidine | cancer | AB | 95-69-2 | 1-Jan-90 | 3 |
p-Chloro-o-toluidine, strong acid salts of | cancer | AB | --- | 15-May-98 | |
p-Chloro-o-toluidine, hydrochloride | 3.3 | ||||
5-Chloro-o-toluidine and its strong acid salts | cancer | SQE | --- | 24-Oct-97 | |
Chlorotrianisene | cancer | FR | 569-57-3 | 1-Sep-96 | |
Chlorozotocin | cancer | AB | 54749-90-5 | 1-Jan-92 | 0.003 |
Chlorsulfuron Delisted June 6, 2014 [Click here for the basis for delisting] |
|
14-May-99 | |||
Chromium (hexavalent compounds) | cancer | LC | --- | 27-Feb-87 | 0.001 (inhalation) |
Chromium (hexavalent compounds) | developmental, female, male | SQE | --- | 19-Dec-08 | 8.2 (oral) |
Chrysene | cancer | AB | 218-01-9 | 1-Jan-90 | 0.35 (oral) |
C.I. Acid Red 114 | cancer | AB | 6459-94-5 | 1-Jul-92 | |
C.I. Basic Red 9 monohydrochloride | cancer | SQE | 569-61-9 | 1-Jul-89 | 3 |
C.I. Direct Blue 15 | cancer | AB | 2429-74-5 | 26-Aug-97 | |
C.I. Direct Blue 218 | cancer | AB | 28407-37-6 | 26-Aug-97 | 50 |
C.I. Disperse Yellow 3 | cancer | SQE | 2832-40-8 | 8-Feb-13 | |
C.I. Solvent Yellow 14 | cancer | AB | 842-07-9 | 15-May-98 | |
Ciclosporin (Cyclosporin A; Cyclosporine) | cancer | AB | 59865-13-3; 79217-60-0 | 1-Jan-92 | |
Cidofovir | cancer, developmental, female, male | FR | 113852-37-2 | 29-Jan-99 | |
Cinnamyl anthranilate | cancer | SQE | 87-29-6 | 1-Jul-89 | 200 |
Cisplatin | cancer | SQE | 15663-27-1 | 1-Oct-88 | |
Citrus Red No. 2 | cancer | LC | 6358-53-8 | 1-Oct-89 | |
Cladribine | developmental | FR | 4291-63-8 | 1-Sep-96 | |
Clarithromycin | developmental | FR | 81103-11-9 | 1-May-97 | |
Clobetasol propionate | developmental, female | FR | 25122-46-7 | 15-May-98 | |
Clofibrate | cancer | FR | 637-07-0 | 1-Sep-96 | |
Clomiphene citrate | cancer | FR | 50-41-9 | 24-May-13 | |
Clomiphene citrate | developmental | FR | 50-41-9 | 1-Apr-90 | |
Clorazepate dipotassium | developmental | FR | 57109-90-7 | 1-Oct-92 | |
Cobalt metal powder | cancer | AB | 7440-48-4 | 1-Jul-92 | |
Cobalt [II] oxide | cancer | AB | 1307-96-6 | 1-Jul-92 | |
Cobalt sulfate | cancer | LC | 10124-43-3 | 20-May-05 | |
Cobalt sulfate heptahydrate | cancer | AB | 10026-24-1 | 2-Jun-00 | |
Cocaine | developmental, female | SQE | 50-36-2 | 1-Jul-89 | |
Coconut oil diethanolamine condensate (cocamide diethanolamine) | cancer | LC | 68603-42-9 | 22-Jun-12 | |
Codeine phosphate | developmental | FR | 52-28-8 | 15-May-98 | |
Coke oven emissions | cancer | LC | --- | 27-Feb-87 | 0.3 |
Colchicine | developmental, male | FR | 64-86-8 | 1-Oct-92 | |
Conjugated estrogens | cancer | LC | --- | 27-Feb-87 | |
Conjugated estrogens | developmental | FR | --- | 1-Apr-90 | |
Creosotes | cancer | SQE | --- | 1-Oct-88 | |
p-Cresidine | cancer | SQE | 120-71-8 | 1-Jan-88 | 5 |
Cumene | cancer | AB | 98-82-8 | 6-Apr-10 | |
Cupferron | cancer | SQE | 135-20-6 | 1-Jan-88 | 3 |
Cyanazine | developmental | FR | 21725-46-2 | 1-Apr-90 | |
Cycasin | cancer | SQE | 14901-08-7 | 1-Jan-88 | |
Cycloate | developmental | AB | 1134-23-2 | 19-Mar-99 | |
Cyclohexanol Delisted January 25, 2002 [Click here for the basis for delisting] | |||||
Cycloheximide | developmental | FR | 66-81-9 | 1-Jan-89 | |
Cyclopenta[cd]pyrene | cancer | LC | 27208-37-3 | 29-Apr-11 | |
Cyclophosphamide (anhydrous) | cancer | LC | 50-18-0 | 27-Feb-87 | 1 |
Cyclophosphamide (anhydrous) | developmental, female, male | SQE - developmental FR - female, male | 50-18-0 | 1-Jan-89 | |
Cyclophosphamide (hydrated) | cancer | LC | 6055-19-2 | 27-Feb-87 | 1 |
Cyclophosphamide (hydrated) | developmental, female, male | SQE - developmental FR - female, male | 6055-19-2 | 1-Jan-89 | |
Cyhexatin | developmental | FR | 13121-70-5 | 1-Jan-89 | |
Cytarabine | developmental | SQE | 147-94-4 | 1-Jan-89 | |
Cytembena | cancer | AB | 21739-91-3 | 15-May-98 | |
D&C Orange No. 17 | cancer | AB | 3468-63-1 | 1-Jul-90 | |
D&C Red No. 8 | cancer | AB | 2092-56-0 | 1-Oct-90 | |
D&C Red No. 9 | cancer | AB | 5160-02-1 | 1-Jul-90 | 100 |
D&C Red No. 19 | cancer | AB | 81-88-9 | 1-Jul-90 | |
Dacarbazine | cancer | SQE | 4342-03-4 | 1-Jan-88 | 0.01 |
Dacarbazine | developmental | FR | 4342-03-4 | 29-Jan-99 | |
Daminozide | cancer | AB | 1596-84-5 | 1-Jan-90 | 40 |
Danazol | developmental | FR | 17230-88-5 | 1-Apr-90 | |
Dantron (Chrysazin; 1,8-Dihydroxyanthraquinone) | cancer | AB | 117-10-2 | 1-Jan-92 | 9 |
Daunomycin | cancer | SQE | 20830-81-3 | 1-Jan-88 | |
Daunorubicin hydrochloride | developmental | FR | 23541-50-6 | 1-Jul-90 | |
2,4-D butyric acid [Click here for the basis for the removal of developmental endpoint, effective June 22, 2001] |
|
AB | 94-82-6 | 18-Jun-99 | 910 |
DDD (Dichlorodiphenyl-dichloroethane) | cancer | SQE | 72-54-8 | 1-Jan-89 | 2 (DDT, DDE, DDD in combination) |
DDE (Dichlorodiphenyl-dichloroethylene) | cancer | SQE | 72-55-9 | 1-Jan-89 | 2 (DDT, DDE, DDD in combination) |
DDT (Dichlorodiphenyl-trichloroethane) | cancer | SQE | 50-29-3 | 1-Oct-87 | 2 (DDT, DDE, DDD in combination) |
o,p'-DDT | developmental, female, male | AB | 789-02-6 | 15-May-98 | |
p,p'-DDT | developmental, female, male | AB | 50-29-3 | 15-May-98 | |
DDVP (Dichlorvos) | cancer | SQE | 62-73-7 | 1-Jan-89 | 2 |
2,4-DP (dichloroprop) Delisted January 25, 2002 [Click here for the basis for delisting] | |||||
Demeclocycline hydrochloride (internal use) | developmental | FR | 64-73-3 | 1-Jan-92 | |
N,N'-Diacetylbenzidine | cancer | LC | 613-35-4 | 1-Oct-89 | |
2,4-Diaminoanisole | cancer | FR | 615-05-4 | 1-Oct-90 | 30 |
2,4-Diaminoanisole sulfate | cancer | SQE | 39156-41-7 | 1-Jan-88 | 50 |
4,4'-Diaminodiphenyl ether (4,4'-Oxydianiline) | cancer | SQE | 101-80-4 | 1-Jan-88 | 5 |
2,4-Diaminotoluene | cancer | SQE | 95-80-7 | 1-Jan-88 | 0.2 |
Diaminotoluene (mixed) | cancer | AB | --- | 1-Jan-90 | |
Diazepam | developmental | FR | 439-14-5 | 1-Jan-92 | |
Diazoaminobenzene | cancer | LC | 136-35-6 | 20-May-05 | |
Diazoxide | developmental | FR | 364-98-7 | 27-Feb-01 | |
Dibenz[a,h]acridine | cancer | SQE | 226-36-8 | 1-Jan-88 | |
Dibenz[a,j]acridine | cancer | SQE | 224-42-0 | 1-Jan-88 | |
Dibenz[a,h]anthracene | cancer | SQE | 53-70-3 | 1-Jan-88 | 0.2 |
7H-Dibenzo[c,g]carbazole | cancer | SQE | 194-59-2 | 1-Jan-88 | 0.0030 (oral) |
Dibenzo[a,e]pyrene | cancer | SQE | 192-65-4 | 1-Jan-88 | |
Dibenzo[a,h]pyrene | cancer | SQE | 189-64-0 | 1-Jan-88 | 0.0054 (oral) |
Dibenzo[a,i]pyrene | cancer | SQE | 189-55-9 | 1-Jan-88 | 0.0050 (oral) |
Dibenzo[a,l]pyrene | cancer | SQE | 191-30-0 | 1-Jan-88 | |
Dibromoacetic acid | cancer | AB | 631-64-1 | 17-Jun-08 | |
Dibromoacetonitrile | cancer | AB | 3252-43-5 | 3-May-11 | |
1,2-Dibromo-3-chloropropane (DBCP) | cancer | FR | 96-12-8 | 1-Jul-87 | 0.1 |
1,2-Dibromo-3-chloropropane (DBCP) [Basis for listing changed effective November 22, 2013] | male | FR | 96-12-8 | 27-Feb-87 | 3.1 (oral) 4.3 (inhalation) |
2,3-Dibromo-1-propanol | cancer | AB | 96-13-9 | 1-Oct-94 | |
Dichloroacetic acid | cancer | AB | 79-43-6 | 1-May-96 | |
Dichloroacetic acid | developmental, male | AB | 79-43-6 | 7-Aug-09 | |
p-Dichlorobenzene | cancer | SQE | 106-46-7 | 1-Jan-89 | 20 |
3,3'-Dichlorobenzidine | cancer | SQE | 91-94-1 | 1-Oct-87 | 0.6 |
3,3'-Dichlorobenzidine dihydrochloride | cancer | AB | 612-83-9 | 15-May-98 | |
1,1-Dichloro-2,2-bis(p-chloropheny)ethylene (DDE) | developmental, male | AB | 72-55-9 | 30-Mar-10 | |
1,4-Dichloro-2-butene | cancer | AB | 764-41-0 | 1-Jan-90 | |
3,3'-Dichloro-4,4'-diamino-diphenyl ether | cancer | SQE | 28434-86-8 | 1-Jan-88 | |
1,1-Dichloroethane | cancer | AB | 75-34-3 | 1-Jan-90 | 100 |
Dichloromethane (Methylene chloride) | cancer | SQE | 75-09-2 | 1-Apr-88 | 50 200 (inhalation) |
Dichlorophene | developmental | AB | 97-23-4 | 27-Apr-99 | |
Dichlorphenamide | developmental | FR | 120-97-8 | 27-Feb-01 | |
1,2-Dichloropropane | cancer | AB | 78-87-5 | 1-Jan-90 | 9.7 |
1,3-Dichloro-2-propanol (1,3-DCP) | cancer | SQE | 96-23-1 | 8-Oct-10 | |
1,3-Dichloropropene | cancer | SQE | 542-75-6 | 1-Jan-89 | |
Diclofop-methyl | cancer | AB | 51338-27-3 | 6-Apr-10 | |
Diclofop methyl | developmental | AB | 51338-27-3 | 5-Mar-99 | |
Dicumarol | developmental | FR | 66-76-2 | 1-Oct-92 | |
Dieldrin | cancer | SQE | 60-57-1 | 1-Jul-88 | 0.04 |
Dienestrol Delisted January 4, 2013 [Click here for the basis for delisting] | |||||
Diepoxybutane | cancer | SQE | 1464-53-5 | 1-Jan-88 | |
Diesel engine exhaust | cancer | AB | --- | 1-Oct-90 | |
Diethanolamine | cancer | LC | 111-42-2 | 22-Jun-12 | |
Di(2-ethylhexyl)phthalate | cancer | SQE | 117-81-7 | 1-Jan-88 | 310 |
Di(2-ethylhexyl)phthalate | developmental, male | AB | 117-81-7 | 24-Oct-03 | |
Adultb | 4200 (intravenous) | ||||
Infant boys, age 29 days to 24 monthsb | 600 (intravenous) | ||||
Neonatal infant boys, age 0 to 28 daysb | 210 (intravenous) | ||||
Adultb | 410 (oral) | ||||
Infant boys, age 29 days to 24 monthsb | 58 (oral) | ||||
Neonatal infant boys, age 0 to 28 daysb | 20 (oral) | ||||
1,2-Diethylhydrazine | cancer | SQE | 1615-80-1 | 1-Jan-88 | |
Diethylstilbestrol (DES) | cancer | LC | 56-53-1 | 27-Feb-87 | 0.002 |
Diethylstilbestrol (DES) | developmental | FR | 56-53-1 | 1-Jul-87 | |
Diethyl sulfate | cancer | SQE | 64-67-5 | 1-Jan-88 | |
Diflunisal | developmental, female | FR | 22494-42-4 | 29-Jan-99 | |
Diglycidyl ether Delisted April 4, 2014 [Click here for the basis for delisting] | |||||
Diglycidyl resorcinol ether (DGRE) | cancer | SQE | 101-90-6 | 1-Jul-89 | 0.4 |
Dihydroergotamine mesylate | developmental | FR | 6190-39-2 | 1-May-97 | |
Dihydrosafrole | cancer | SQE | 94-58-6 | 1-Jan-88 | 20 |
Diisononyl phthalate (DINP) | cancer | SQE | --- | 20-Dec-13 | |
Diisopropyl sulfate | cancer | AB | 2973-10-6 | 1-Apr-93 | |
Di-isodecyl phthalate (DIDP) | developmental | AB | 68515-49-1/ 26761-40-0 | 20-Apr-07 | 2200 |
Diltiazem hydrochloride | developmental | FR | 33286-22-5 | 27-Feb-01 | |
3,3'-Dimethoxybenzidine (o-Dianisidine) | cancer | SQE | 119-90-4 | 1-Jan-88 | 0.15 |
3,3'-Dimethoxybenzidine dihydrochloride | cancer | AB | 20325-40-0 | 1-Oct-90 | 0.19 |
3,3'-Dimethoxybenzidine-based dyes metabolized to 3,3'-dimethoxybenzidine | cancer | AB | --- | 11-Jun-04 | |
N,N-Dimethylacetamide [Click here for the basis for addition of male reproductive endpoint, effective December 20, 2013] | developmental, male | SQE | 127-19-5 | 21-May-10 | |
4-Dimethylaminoazobenzene | cancer | SQE | 60-11-7 | 1-Jan-88 | 0.2 |
trans-2-[(Dimethylamino)methylimino]-5-[2-(5-nitro-2-furyl)vinyl]-1,3,4-oxadiazole | cancer | SQE | 55738-54-0 | 1-Jan-88 | 2 |
7,12-Dimethylbenz(a)anthracene | cancer | AB | 57-97-6 | 1-Jan-90 | 0.003 |
3,3'-Dimethylbenzidine (ortho-Tolidine) | cancer | SQE | 119-93-7 | 1-Jan-88 | 0.044 |
3,3'-Dimethylbenzidine dihydrochloride | cancer | AB | 612-82-8 | 1-Apr-92 | 0.059 |
3,3'-Dimethylbenzidine-based dyes metabolized to 3,3'-dimethylbenzidine | cancer | AB | --- | 11-Jun-04 | |
Dimethylcarbamoyl chloride | cancer | SQE | 79-44-7 | 1-Jan-88 | 0.05 |
1,1-Dimethylhydrazine (UDMH) | cancer | LC | 57-14-7 | 1-Oct-89 | |
1,2-Dimethylhydrazine | cancer | SQE | 540-73-8 | 1-Jan-88 | 0.001 |
2,6-Dimethyl-N-nitrosomorpholine (DMNM) | cancer | SQE | 1456-28-6 | 8-Feb-13 | |
Dimethyl sulfate | cancer | SQE | 77-78-1 | 1-Jan-88 | |
N,N-Dimethyl-p-toluidine | cancer | AB | 99-97-8 | 2-May-14 | |
Dimethylvinylchloride | cancer | SQE | 513-37-1 | 1-Jul-89 | 20 |
Di-n-butyl phthalate (DBP) | developmental, female, male | AB | 84-74-2 | 2-Dec-05 | 8.7 |
Di-n-hexyl phthalate (DnHP) | female, male | AB | 84-75-3 | 2-Dec-05 | 2200 (oral) |
m-Dinitrobenzene | male | AB | 99-65-0 | 1-Jul-90 | 38 |
o-Dinitrobenzene | male | AB | 528-29-0 | 1-Jul-90 | |
p-Dinitrobenzene | male | AB | 100-25-4 | 1-Jul-90 | |
3,7-Dinitrofluoranthene | cancer | AB | 105735-71-5 | 26-Aug-97 | |
3,9-Dinitrofluoranthene | cancer | AB | 22506-53-2 | 26-Aug-97 | |
1,3-Dinitropyrene | cancer | LC | 75321-20-9 | 2-Nov-12 | |
1,6-Dinitropyrene | cancer | AB | 42397-64-8 | 1-Oct-90 | |
1,8-Dinitropyrene | cancer | AB | 42397-65-9 | 1-Oct-90 | |
2,4-Dinitrotoluene | cancer | SQE | 121-14-2 | 1-Jul-88 | 2 |
2,4-Dinitrotoluene | male | AB | 121-14-2 | 20-Aug-99 | |
2,6-Dinitrotoluene | cancer | SQE | 606-20-2 | 1-Jul-95 | |
2,6-Dinitrotoluene | male | AB | 606-20-2 | 20-Aug-99 | |
Dinitrotoluene (technical grade) | female, male | AB | --- | 20-Aug-99 | |
Dinitrotoluene mixture, 2,4-/2,6- | cancer | AB | --- | 1-May-96 | |
Dinocap | developmental | FR | 39300-45-3 | 1-Apr-90 | |
Dinoseb | developmental, male | FR | 88-85-7 | 1-Jan-89 | |
Di-n-propyl isocinchomeronate (MGK Repellent 326) | cancer | AB | 136-45-8 | 1-May-96 | |
1,4-Dioxane | cancer | SQE | 123-91-1 | 1-Jan-88 | 30 |
Diphenylhydantoin (Phenytoin) | cancer | SQE | 57-41-0 | 1-Jan-88 | |
Diphenylhydantoin (Phenytoin) | developmental | SQE | 57-41-0 | 1-Jul-87 | |
Diphenylhydantoin (Phenytoin), sodium salt | cancer | SQE | 630-93-3 | 1-Jan-88 | |
Direct Black 38 (technical grade) | cancer | SQE | 1937-37-7 | 1-Jan-88 | 0.09 |
Direct Blue 6 (technical grade) | cancer | SQE | 2602-46-2 | 1-Jan-88 | 0.09 |
Direct Brown 95 (technical grade) | cancer | SQE | 16071-86-6 | 1-Oct-88 | 0.1 |
Disodium cyanodithioimidocarbonate | developmental | AB | 138-93-2 | 30-Mar-99 | 56 (oral) 170 (oral) as 32% pesticidal formulation |
Disperse Blue 1 | cancer | AB | 2475-45-8 | 1-Oct-90 | 200 |
Diuron | cancer | AB | 330-54-1 | 31-May-02 | |
Doxorubicin hydrochloride (Adriamycin) | cancer | SQE | 25316-40-9 | 1-Jul-87 | |
Doxorubicin hydrochloride (Adriamycin) | developmental, male | FR | 25316-40-9 | 29-Jan-99 | |
Doxycycline (internal use) | developmental | FR | 564-25-0 | 1-Jul-90 | |
Doxycycline calcium (internal use) | developmental | FR | 94088-85-4 | 1-Jan-92 | |
Doxycycline hyclate (internal use) | developmental | FR | 24390-14-5 | 1-Oct-91 | |
Doxycycline monohydrate (internal use) | developmental | FR | 17086-28-1 | 1-Oct-91 | |
Emissions from combustion of coal | cancer | AB | --- | 7-Aug-13 | |
Emissions from high-temperature unrefined rapeseed oil | cancer | AB | --- | 3-Jan-14 | |
Endrin | developmental | AB | 72-20-8 | 15-May-98 | |
Environmental tobacco smoke (ETS) | developmental | SQE | --- | 9-Jun-06 | |
Epichlorohydrin | cancer | SQE | 106-89-8 | 1-Oct-87 | 9 |
Epichlorohydrin | male | AB | 106-89-8 | 1-Sep-96 | |
Epoxiconazole | cancer | AB | 135319-73-2 | 15-Apr-11 | |
Ergotamine tartrate | developmental | FR | 379-79-3 | 1-Apr-90 | |
Erionite | cancer | SQE | 12510-42-8; 66733-21-9 | 1-Oct-88 | |
Estradiol 17B | cancer | SQE | 50-28-2 | 1-Jan-88 | 0.02 |
Estragole | cancer | SQE | 140-67-0 | 29-Oct-99 | |
Estrogens, steroidal | cancer | LC | --- | 19-Aug-05 | |
Estrogen-progestogen (combined) used as menopausal therapy | cancer | LC | --- | 4-Nov-11 | |
Estrone | cancer | SQE | 53-16-7 | 1-Jan-88 | |
Estropipate | cancer, developmental | FR | 7280-37-7 | 26-Aug-97 | |
Ethanol in alcoholic beverages | cancer | LC | --- | 29-Apr-11 | |
Ethinylestradiol | cancer | SQE | 57-63-6 | 1-Jan-88 | |
Ethionamide | developmental | FR | 536-33-4 | 26-Aug-97 | |
Ethoprop | cancer | AB | 13194-48-4 | 27-Feb-01 | |
Ethyl acrylate | cancer | SQE | 140-88-5 | 1-Jul-89 | |
Ethyl alcohol in alcoholic beverages | developmental | SQE | --- | 1-Oct-87 | |
Ethylbenzene | cancer | AB | 100-41-4 | 11-Jun-04 | 54 (inhalation) 41 (oral) |
Ethyl-tert-butyl ether Delisted December 13, 2013 [Clik here for the basis for delisting] | |||||
Ethyl dipropylthiocarbamate | developmental | AB | 759-94-4 | 27-Apr-99 | 700 (oral and inhalation) 6700 (dermal) |
Ethyl-4,4'-dichlorobenzilate | cancer | AB | 510-15-6 | 1-Jan-90 | 7 |
Ethylene dibromide | cancer | FR | 106-93-4 | 1-Jul-87 | 0.2 (oral) 3 (inhalation) |
Ethylene dibromide | developmental, male | AB | 106-93-4 | 15-May-98 | |
Ethylene dichloride (1,2-Dichloroethane) | cancer | SQE | 107-06-2 | 1-Oct-87 | 10 |
Ethylene glycol monoethyl ether | developmental, male | SQE | 110-80-5 | 1-Jan-89 | 750 (oral) 960 (inhalation) |
Ethylene glycol monoethyl ether acetate | developmental, male | AB | 111-15-9 | 1-Jan-93 | 1100 (oral) 1400 (inhalation) |
Ethylene glycol monomethyl ether | developmental, male | SQE | 109-86-4 | 1-Jan-89 | 63 (oral) |
Ethylene glycol monomethyl ether acetate | developmental, male | AB | 110-49-6 | 1-Jan-93 | 98 (oral) |
Ethyleneimine | cancer | SQE | 151-56-4 | 1-Jan-88 | 0.01 |
Ethylene oxide | cancer | FR | 75-21-8 | 1-Jul-87 | 2 |
Ethylene oxide [Basis for listing changed effective November 22, 2013] | female | FR | 75-21-8 | 27-Feb-87 | 20 |
Ethylene oxide [Basis for listing changed effective November 22, 2013] | developmental, male | FR | 75-21-8 | 7-Aug-09 | |
Ethylene thiourea | cancer | AB | 96-45-7 | 1-Jan-88 | 20 |
Ethylene thiourea | developmental | SQE | 96-45-7 | 1-Jan-93 | |
2-Ethylhexanoic acid Delisted December 13, 2013 [Click here for the basis for delisting] | |||||
Ethyl methanesulfonate | cancer | SQE | 62-50-0 | 1-Jan-88 | |
Etodolac | developmental, female | FR | 41340-25-4 | 20-Aug-99 | |
Etoposide | cancer | LC | 33419-42-0 | 4-Nov-11 | |
Etoposide | developmental | FR | 33419-42-0 | 1-Jul-90 | |
Etoposide in combination with cisplatin and bleomycin | cancer | LC | --- | 4-Nov-11 | |
Etretinate | developmental | SQE | 54350-48-0 | 1-Jul-87 | |
Fenoxaprop ethyl | developmental | AB | 66441-23-4 | 26-Mar-99 | |
Fenoxycarb | cancer | AB | 72490-01-8 | 2-Jun-00 | |
Filgrastim | developmental | FR | 121181-53-1 | 27-Feb-01 | |
Fluazifop butyl | developmental | AB | 69806-50-4 | 6-Nov-98 | |
Flunisolide | developmental, female | FR | 3385-03-3 | 15-May-98 | |
Fluorouracil | developmental | SQE | 51-21-8 | 1-Jan-89 | |
Fluoxymesterone | developmental | FR | 76-43-7 | 1-Apr-90 | |
Flurazepam hydrochloride | developmental | FR | 1172-18-5 | 1-Oct-92 | |
Flurbiprofen | developmental, female | FR | 5104-49-4 | 20-Aug-99 | |
Flutamide | developmental | FR | 13311-84-7 | 1-Jul-90 | |
Fluticasone propionate | developmental | FR | 80474-14-2 | 15-May-98 | |
Fluvalinate | developmental | AB | 69409-94-5 | 6-Nov-98 | |
Folpet | cancer | SQE | 133-07-3 | 1-Jan-89 | 200 |
Formaldehyde (gas) | cancer | SQE | 50-00-0 | 1-Jan-88 | 40 |
2-(2-Formylhydrazino)-4-(5-nitro-2-furyl)thiazole | cancer | SQE | 3570-75-0 | 1-Jan-88 | 0.3 |
Fumonisin B1 | cancer | AB | 116355-83-0 | 14-Nov-03 | |
Furan | cancer | AB | 110-00-9 | 1-Oct-93 | |
Furazolidone | cancer | AB | 67-45-8 | 1-Jan-90 | |
Furmecyclox | cancer | AB | 60568-05-0 | 1-Jan-90 | 20 |
Fusarin C | cancer | SQE | 79748-81-5 | 1-Jul-95 | |
Gallium arsenide | cancer | LC | 1303-00-0 | 1-Aug-08 | |
Ganciclovir | cancer, developmental, male | FR | 82410-32-0 | 26-Aug-97 | |
Ganciclovir sodium | developmental, male | FR | 107910-75-8 | 26-Aug-97 | |
Gasoline engine exhaust (condensates/extracts) | cancer | AB | --- | 1-Oct-90 | |
Gemfibrozil | cancer | FR | 25812-30-0 | 22-Dec-00 | |
Gemfibrozil | female, male | FR | 25812-30-0 | 20-Aug-99 | |
Glass wool fibers (inhalable and biopersistent) | cancer | AB | --- | 1-Jul-90 | |
Glu-P-1 (2-Amino-6-methyldipyrido[1,2- a:3',2'-d]imidazole) | cancer | AB | 67730-11-4 | 1-Jan-90 | 0.1 |
Glu-P-2 (2-Aminodipyrido[1,2-a:3',2'-d]imidazole) | cancer | AB | 67730-10-3 | 1-Jan-90 | 0.5 |
Glycidaldehyde | cancer | SQE | 765-34-4 | 1-Jan-88 | |
Glycidol | cancer | AB | 556-52-5 | 1-Jul-90 | 0.54 |
Goserelin acetate | developmental, female, male | FR | 65807-02-5 | 26-Aug-97 | |
Griseofulvin | cancer | AB | 126-07-8 | 1-Jan-90 | |
Gyromitrin (Acetaldehyde methylformylhydrazone) | cancer | SQE | 16568-02-8 | 1-Jan-88 | 0.07 |
Halazepam | developmental | FR | 23092-17-3 | 1-Jul-90 | |
Halobetasol propionate | developmental | FR | 66852-54-8 | 20-Aug-99 | |
Haloperidol | developmental, female | FR | 52-86-8 | 29-Jan-99 | |
Halothane | developmental | FR | 151-67-7 | 1-Sep-96 | |
HC Blue 1 | cancer | SQE | 2784-94-3 | 1-Jul-89 | 10 |
Heptachlor | cancer | SQE | 76-44-8 | 1-Jul-88 | 0.2 |
Heptachlor | developmental | AB | 76-44-8 | 20-Aug-99 | |
Heptachlor epoxide | cancer | SQE | 1024-57-3 | 1-Jul-88 | 0.08 |
Herbal remedies containing plant species of the genus Aristolochia | cancer | LC | --- | 9-Jul-04 | |
Hexachlorobenzene | cancer | SQE | 118-74-1 | 1-Oct-87 | 0.4 |
Hexachlorobenzene | developmental | SQE | 118-74-1 | 1-Jan-89 | |
Hexachlorobutadiene | cancer | AB | 87-68-3 | 3-May-11 | |
Hexachlorocyclohexane (technical grade) | cancer | SQE | --- | 1-Oct-87 | 0.2 |
Hexachlorocyclohexane (alpha isomer) | 0.3 | ||||
Hexachlorocyclohexane (beta isomer) | 0.5 | ||||
Hexachlorocyclohexane (gamma isomer) | 0.6 | ||||
Hexachlorodibenzodioxin | cancer | SQE | 34465-46- 8 | 1-Apr-88 | 0.0002 |
Hexachloroethane | cancer | AB | 67-72-1 | 1-Jul-90 | 20 |
2,4-Hexadienal (89% trans, trans isomer; 11% cis, trans isomer) | cancer | AB | --- | 4-Mar-05 | |
Hexafluoroacetone [Basis for listing changed effective June 6, 2014] | developmental, male | 684-16-2 | 1-Aug-08 | ||
Hexamethylphosphoramide | cancer | SQE | 680-31-9 | 1-Jan-88 | |
Hexamethylphosphoramide | male | AB | 680-31-9 | 1-Oct-94 | |
Histrelin acetate | developmental | FR | --- | 15-May-98 | |
Hydramethylnon | developmental, male | AB | 67485-29-4 | 5-Mar-99 | 120 (oral) |
Hydrazine | cancer | SQE | 302-01-2 | 1-Jan-88 | 0.04 |
Hydrazine sulfate | cancer | SQE | 10034-93-2 | 1-Jan-88 | 0.2 |
Hydrazobenzene (1,2-Diphenylhydrazine) | cancer | SQE | 122-66-7 | 1-Jan-88 | 0.8 |
Hydrogen cyanide (HCN) and cyanide salts (CN salts) | male | AB | --- | 5-Jul-13 | |
Cyanide salts that readily dissociate in solution (expressed as cyanide)f | 9.8 | ||||
Hydrogen cyanidef | 10 (oral) | ||||
Sodium cyanidef | 19 (oral) | ||||
Potassium cyanidef | 25 (oral) | ||||
1-Hydroxyanthraquinone | cancer | LC | 129-43-1 | 27-May-05 | |
Hydroxyurea | developmental | FR | 127-07-1 | 1-May-97 | |
Idarubicin hydrochloride | developmental, male | FR | 57852-57-0 | 20-Aug-99 | |
Ifosfamide | developmental | FR | 3778-73-2 | 1-Jul-90 | |
Iodine-131 | developmental | SQE | 10043-66-0 | 1-Jan-89 | |
Imazalil | cancer | AB | 35554-44-0 | 20-May-11 | 11 |
Indeno [1,2,3-cd]pyrene | cancer | SQE | 193-39-5 | 1-Jan-88 | |
Indium phosphide | cancer | AB | 22398-80-7 | 27-Feb-01 | |
IQ (2-Amino-3-methylimidazo[4,5-f] quinoline) | cancer | AB | 76180-96-6 | 1-Apr-90 | 0.5 |
Iprodione | cancer | AB | 36734-19-7 | 1-May-96 | |
Iprovalicarb | cancer | AB | 140923-17-7/ 140923-25-7 | 1-Jun-07 | |
Iron dextran complex | cancer | SQE | 9004-66-4 | 1-Jan-88 | |
Isobutyl nitrite | cancer | AB | 542-56-3 | 1-May-96 | 7.4 |
Isoprene | cancer | AB | 78-79-5 | 1-May-96 | |
Isopyrazam | cancer | AB | 881685-58-1 | 24-Jul-12 | |
Isosafrole Delisted December 8, 2006 [Click here for the basis for delisting] | |||||
Isotretinoin | developmental | SQE | 4759-48-2 | 1-Jul-87 | |
Isoxaflutole | cancer | AB | 141112-29-0 | 22-Dec-00 | |
Kresoxim-methyl | cancer | AB | 143390-89-0 | 3-Feb-12 | |
Lactofen | cancer | SQE | 77501-63-4 | 1-Jan-89 | |
Lasiocarpine | cancer | SQE | 303-34-4 | 1-Apr-88 | 0.09 |
Lead [Basis for listing changed effective November 22, 2013] | developmental, female, male | FR | --- | 27-Feb-87 | 0.5 |
Lead and lead compounds | cancer | AB | --- | 1-Oct-92 | |
Lead | 15 (oral) | ||||
Lead acetate | cancer | SQE | 301-04-2 | 1-Jan-88 | 23 (oral) |
Lead phosphate | cancer | SQE | 7446-27-7 | 1-Apr-88 | 58 (oral) |
Lead subacetate | cancer | LC | 1335-32-6 | 1-Oct-89 | 41 (oral) |
Leather dust | cancer | LC | --- | 29-Apr-11 | |
Leuprolide acetate | developmental, female, male | FR | 74381-53-6 | 26-Aug-97 | |
Levodopa | developmental | FR | 59-92-7 | 29-Jan-99 | |
Levonorgestrel implants | female | FR | 797-63-7 | 15-May-98 | |
Lindane and other hexachlorocyclohexane isomers | cancer | LC | --- | 1-Oct-89 | |
Linuron | developmental | AB | 330-55-2 | 19-Mar-99 | 460 |
Lithium carbonate | developmental | FR | 554-13-2 | 1-Jan-91 | |
Lithium citrate | developmental | FR | 919-16-4 | 1-Jan-91 | |
Lorazepam | developmental | FR | 846-49-1 | 1-Jul-90 | |
Lovastatin | developmental | FR | 75330-75-5 | 1-Oct-92 | |
Lynestrenol | cancer | AB | 52-76-6 | 27-Feb-01 | |
Malonaldehyde, sodium salt | cancer | AB | 24382-04-5 | 29-Apr-11 | |
Mancozeb | cancer | AB | 8018-01-7 | 1-Jan-90 | |
Maneb | cancer | AB | 12427-38-2 | 1-Jan-90 | |
Marijuana smoke | cancer | SQE | --- | 19-Jun-09 | |
Me-A-alpha-C (2-Amino-3-methyl-9H-pyrido[2,3-b]indole) | cancer | AB | 68006-83-7 | 1-Jan-90 | 0.6 |
Mebendazole | developmental | FR | 31431-39-7 | 20-Aug-99 | |
Medroxyprogesterone acetate | cancer | AB | 71-58-9 | 1-Jan-90 | |
Medroxyprogesterone acetate | developmental | FR | 71-58-9 | 1-Apr-90 | |
Megestrol acetate | cancer | FR | 595-33-5 | 28-Mar-14 | |
Megestrol acetate | developmental | FR | 595-33-5 | 1-Jan-91 | |
MeIQ (2-Amino-3,4-dimethylimidazo[4,5-f]quinoline) | cancer | AB | 77094-11-2 | 1-Oct-94 | 0.46 |
MeIQx (2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline) | cancer | AB | 77500-04-0 | 1-Oct-94 | 0.41 |
Melphalan | cancer | LC | 148-82-3 | 27-Feb-87 | 0.005 |
Melphalan | developmental | FR | 148-82-3 | 1-Jul-90 | |
Menotropins | developmental | FR | 9002-68-0 | 1-Apr-90 | |
Mepanipyrim | cancer | AB | 110235-47-7 | 1-Jul-08 | |
Meprobamate | developmental | FR | 57-53-4 | 1-Jan-92 | |
Mercaptopurine | developmental | FR | 6112-76-1 | 1-Jul-90 | |
Mercury and mercury compounds | developmental | AB | --- | 1-Jul-90 | |
Merphalan | cancer | SQE | 531-76-0 | 1-Apr-88 | |
Mestranol | cancer | SQE | 72-33-3 | 1-Apr-88 | |
Metam potassium | cancer | AB | 137-41-7 | 31-Dec-10 | |
Methacycline hydrochloride | developmental | FR | 3963-95-9 | 1-Jan-91 | |
Metham sodium | cancer | AB | 137-42-8 | 6-Nov-98 | |
Metham sodium | developmental | AB | 137-42-8 | 15-May-98 | |
Methanol | developmental | AB | 67-56-1 | 16-Mar-12 | 47,000 (inhalation) 23,000 (oral) |
Methazole | developmental | AB | 20354-26-1 | 1-Dec-99 | |
Methimazole | developmental | FR | 60-56-0 | 1-Jul-90 | |
Methotrexate | developmental | SQE | 59-05-2 | 1-Jan-89 | |
Methotrexate sodium | developmental | FR | 15475-56-6 | 1-Apr-90 | |
5-Methoxypsoralen with ultraviolet A therapy | cancer | SQE | 484-20-8 | 1-Oct-88 | |
8-Methoxypsoralen with ultraviolet A therapy | cancer | LC | 298-81-7 | 27-Feb-87 | |
2-Methylaziridine (Propyleneimine) | cancer | SQE | 75-55-8 | 1-Jan-88 | 0.028 |
Methylazoxymethanol | cancer | SQE | 590-96-5 | 1-Apr-88 | |
Methylazoxymethanol acetate | cancer | SQE | 592-62-1 | 1-Apr-88 | |
Methyl bromide, as a structural fumigant | developmental | FR | 74-83-9 | 1-Jan-93 | 810 (inhalation) |
Methyl n-butyl ketone | male | LC | 591-78-6 | 7-Aug-09 | |
Methyl carbamate | cancer | AB | 598-55-0 | 15-May-98 | 160 |
Methyl chloride | developmental | AB | 74-87-3 | 10-Mar-00 | |
Methyl chloride [Basis for listing changed effective March 7, 2014] | male | AB | 74-87-3 | 7-Aug-09 | |
3-Methylcholanthrene | cancer | AB | 56-49-5 | 1-Jan-90 | 0.03 |
5-Methylchrysene | cancer | SQE | 3697-24-3 | 1-Apr-88 | 0.0084 (oral) |
4,4'-Methylene bis(2-chloroaniline) | cancer | FR | 101-14-4 | 1-Jul-87 | 0.5 |
4,4'-Methylene bis(N,N-dimethyl)benzenamine | cancer | LC | 101-61-1 | 1-Oct-89 | 20 |
4,4'-Methylene bis(2-methylaniline) | cancer | SQE | 838-88-0 | 1-Apr-88 | 0.8 |
4,4'-Methylenedianiline | cancer | SQE | 101-77-9 | 1-Jan-88 | 0.4 |
4,4'-Methylenedianiline dihydrochloride | cancer | SQE | 13552-44-8 | 1-Jan-88 | 0.6 |
Methyleugenol | cancer | AB | 93-15-2 | 16-Nov-01 | |
Methylhydrazine and its salts | cancer | AB | --- | 1-Jul-92 | |
Methylhydrazine | 0.058 (oral) 0.090 (inhalation) | ||||
Methylhydrazine sulfate | 0.18 | ||||
2-Methylimidazole | cancer | LC | 693-98-1 | 22-Jun-12 | |
4-Methylimidazole | cancer | AB | 822-36-6 | 7-Jan-11 | 29 |
Methyl iodide | cancer | SQE | 74-88-4 | 1-Apr-88 | |
Methyl isobutyl ketone | cancer | LC | 108-10-1 | 4-Nov-11 | |
Methyl isobutyl ketone (MIBK) | developmental | AB | 108-10-1 | 28-Mar-14 | |
Methyl isocyanate (MIC) | developmental, female | SQE | 624-83-9 | 12-Nov-10 | |
Methyl isopropyl ketone Delisted April 4, 2014 [Click for the basis for delisting] | |||||
Methyl mercury | developmental | SQE | --- | 1-Jul-87 | |
Methylmercury compounds | cancer | AB | --- | 1-May-96 | |
Methyl methanesulfonate | cancer | SQE | 66-27-3 | 1-Apr-88 | 7 |
2-Methyl-1-nitroanthraquinone (of uncertain purity) | cancer | SQE | 129-15-7 | 1-Apr-88 | 0.2 |
N-Methyl-N'-nitro-N-nitrosoguanidine | cancer | SQE | 70-25-7 | 1-Apr-88 | 0.08 |
N-Methylolacrylamide | cancer | AB | 924-42-5 | 1-Jul-90 | |
N-Methylpyrrolidone | developmental | AB | 872-50-4 | 15-Jun-01 | 3200 (inhalation) 17000 (dermal) |
α-Methyl styrene (alpha-Methylstyrene) | cancer | LC | 98-83-9 | 2-Nov-12 | |
α-Methyl styrene Delisted April 4, 2014 [Click for the basis for delisting] | |||||
Methyltestosterone | developmental | FR | 58-18-4 | 1-Apr-90 | |
Methylthiouracil | cancer | LC | 56-04-2 | 1-Oct-89 | 2 |
Metiram | cancer | AB | 9006-42-2 | 1-Jan-90 | |
Metiram | developmental | AB | 9006-42-2 | 30-Mar-99 | |
Metronidazole | cancer | SQE | 443-48-1 | 1-Jan-88 | |
Michler's ketone | cancer | SQE | 90-94-8 | 1-Jan-88 | 0.8 |
Midazolam hydrochloride | developmental | FR | 59467-96-8 | 1-Jul-90 | |
Minocycline hydrochloride (internal use) | developmental | FR | 13614-98-7 | 1-Jan-92 | |
Mirex | cancer | SQE | 2385-85-5 | 1-Jan-88 | 0.04 |
Misoprostol | developmental | FR | 59122-46-2 | 1-Apr-90 | |
Mitomycin C | cancer | SQE | 50-07-7 | 1-Apr-88 | 0.00009 |
Mitoxantrone hydrochloride | developmental | FR | 70476-82-3 | 1-Jul-90 | |
Molinate | developmental, female, male | AB | 2212-67-1 | 11-Dec-09 | |
MON 4660 (dichloroacetyl-1-oxa-4-azaspiro(4,5)-decane | cancer | AB | 71526-07-3 | 22-Mar-11 | |
MON 13900 (furilazole) | cancer | AB | 121776-33-8 | 22-Mar-11 | |
3-Monochloropropane-1,2-diol (3-MCDP) | cancer | SQE | 96-24-2 | 8-Oct-10 | |
Monocrotaline | cancer | SQE | 315-22-0 | 1-Apr-88 | 0.07 |
MOPP (vincristine-prednisone-nitrogen mustard-procarbazine mixture) | cancer | LC | 113803-47-7 | 4-Nov-11 | |
5-(Morpholinomethyl)-3-[(5-nitrofurfurylidene)-amino]-2-oxazolidinone | cancer | SQE | 139-91-3 | 1-Apr-88 | 0.18 |
Mustard Gas | cancer | LC | 505-60-2 | 27-Feb-87 | |
MX (3-chloro-4-dichloromethyl-5-hydroxy-2(5H)-furanone) | cancer | SQE | 77439-76-0 | 22-Dec-00 | 0.11 |
Myclobutanil | developmental, male | AB | 88671-89-0 | 16-Apr-99 | |
Nabam | developmental | AB | 142-59-6 | 30-Mar-99 | |
Nafarelin acetate | developmental | FR | 86220-42-0 | 1-Apr-90 | |
Nafenopin | cancer | SQE | 3771-19-5 | 1-Apr-88 | |
Nalidixic acid | cancer | AB | 389-08-2 | 15-May-98 | 28 |
Naphthalene | cancer | AB | 91-20-3 | 19-Apr-02 | 5.8 |
1-Naphthylamine | cancer | LC | 134-32-7 | 1-Oct-89 | |
2-Naphthylamine | cancer | LC | 91-59-8 | 27-Feb-87 | 0.4 |
Neomycin sulfate (internal use) | developmental | FR | 1405-10-3 | 1-Oct-92 | |
Netilmicin sulfate | developmental | FR | 56391-57-2 | 1-Jul-90 | |
Nickel (Metallic) | cancer | LC | 7440-02-0 | 1-Oct-89 | |
Nickel acetate | cancer | LC | 373-02-4 | 1-Oct-89 | |
Nickel carbonate | cancer | LC | 3333-67-3 | 1-Oct-89 | |
Nickel carbonyl | cancer | SQE | 13463-39-3 | 1-Oct-87 | |
Nickel carbonyl | developmental | AB | 13463-39-3 | 1-Sep-96 | |
Nickel compounds | cancer | LC | --- | 7-May-04 | |
Nickel hydroxide | cancer | LC | 12054-48-7; 12125-56-3 | 1-Oct-89 | |
Nickelocene | cancer | LC | 1271-28-9 | 1-Oct-89 | |
Nickel oxide | cancer | LC | 1313-99-1 | 1-Oct-89 | |
Nickel refinery dust from the pyrometallurgical process | cancer | SQE | --- | 1-Oct-87 | 0.8 |
Nickel subsulfide | cancer | SQE | 12035-72-2 | 1-Oct-87 | 0.4 |
Nicotine | developmental | FR | 54-11-5 | 1-Apr-90 | |
Nifedipine | developmental, female, male | FR | 21829-25-4 | 29-Jan-99 | |
Nimodipine | developmental | FR | 66085-59-4 | 24-Apr-01 | |
Niridazole | cancer | SQE | 61-57-4 | 1-Apr-88 | |
Nitrapyrin | cancer | AB | 1929-82-4 | 5-Oct-05 | |
Nitrapyrin | developmental | AB | 1929-82-4 | 30-Mar-99 | |
Nitrilotriacetic acid | cancer | SQE | 139-13-9 | 1-Jan-88 | 100 |
Nitrilotriacetic acid, trisodium salt monohydrate | cancer | SQE | 18662-53-8 | 1-Apr-89 | 70 |
5-Nitroacenaphthene | cancer | SQE | 602-87-9 | 1-Apr-88 | 6 |
5-Nitro-o-anisidine Delisted December 8, 2006 [Click here for the basis for delisting] | |||||
o-Nitroanisole | cancer | AB | 91-23-6 | 1-Oct-92 | |
Nitrobenzene | cancer | AB | 98-95-3 | 26-Aug-97 | |
Nitrobenzene | male | AB | 98-95-3 | 30-Mar-10 | |
4-Nitrobiphenyl | cancer | SQE | 92-93-3 | 1-Apr-88 | |
6-Nitrochrysene | cancer | AB | 7496-02-8 | 1-Oct-90 | |
Nitrofen (technical grade) | cancer | SQE | 1836-75-5 | 1-Jan-88 | 9 |
2-Nitrofluorene | cancer | AB | 607-57-8 | 1-Oct-90 | |
Nitrofurantoin | male | AB | 67-20-9 | 1-Apr-91 | |
Nitrofurazone | cancer | AB | 59-87-0 | 1-Jan-90 | 0.5 |
1-[(5-Nitrofurfurylidene)-amino]-2-imidazolidinone | cancer | SQE | 555-84-0 | 1-Apr-88 | 0.4 |
N-[4-(5-Nitro-2-furyl)-2-thiazolyl]acetamide | cancer | SQE | 531-82-8 | 1-Apr-88 | 0.5 |
Nitrogen mustard (Mechlorethamine) | cancer | SQE | 51-75-2 | 1-Jan-88 | |
Nitrogen mustard (Mechlorethamine) | developmental | SQE | 51-75-2 | 1-Jan-89 | |
Nitrogen mustard hydrochloride (Mechlorethamine hydrochloride) | cancer | SQE | 55-86-7 | 1-Apr-88 | |
Nitrogen mustard hydrochloride (Mechlorethamine hydrochloride) | developmental | FR | 55-86-7 | 1-Jul-90 | |
Nitrogen mustard N-oxide | cancer | SQE | 126-85-2 | 1-Apr-88 | |
Nitrogen mustard N-oxide hydrochloride | cancer | SQE | 302-70-5 | 1-Apr-88 | |
Nitromethane | cancer | AB | 75-52-5 | 1-May-97 | 39 |
2-Nitropropane | cancer | SQE | 79-46-9 | 1-Jan-88 | |
1-Nitropyrene | cancer | AB | 5522-43-0 | 1-Oct-90 | |
4-Nitropyrene | cancer | AB | 57835-92-4 | 1-Oct-90 | |
N-Nitrosodiethanolamine | cancer | SQE | 1116-54-7 | 1-Jan-88 | 0.3 |
N-Nitrosodiethylamine | cancer | SQE | 55-18-5 | 1-Oct-87 | 0.02 |
N-Nitrosodimethylamine | cancer | SQE | 62-75-9 | 1-Oct-87 | 0.04 |
N-Nitrosodi-n-butylamine | cancer | SQE | 924-16-3 | 1-Oct-87 | 0.06 |
N-Nitrosodi-n-propylamine | cancer | SQE | 621-64-7 | 1-Jan-88 | 0.1 |
p-Nitrosodiphenylamine | cancer | SQE | 156-10-5 | 1-Jan-88 | 30 |
N-Nitrosodiphenylamine | cancer | SQE | 86-30-6 | 1-Apr-88 | 80 |
3-(N-Nitrosomethylamino) propionitrile | cancer | AB | 60153-49-3 | 1-Apr-90 | |
4-(N-Nitrosomethylamino)-1-(3-pyridyl)1-butanone | cancer | AB | 64091-91-4 | 1-Apr-90 | 0.014 |
N-Nitrosomethylethylamine | cancer | LC | 10595-95-6 | 1-Oct-89 | 0.03 |
N-Nitrosomethylvinylamine | cancer | SQE | 4549-40-0 | 1-Jan-88 | |
N-Nitrosomorpholine | cancer | SQE | 59-89-2 | 1-Jan-88 | 0.1 |
N-Nitroso-N-ethylurea | cancer | SQE | 759-73-9 | 1-Oct-87 | 0.03 |
N-Nitroso-N-methylurea | cancer | SQE | 684-93-5 | 1-Oct-87 | 0.006 |
N-Nitroso-N-methylurethane | cancer | SQE | 615-53-2 | 1-Apr-88 | 0.006 |
N-Nitrosonornicotine | cancer | SQE | 16543-55-8 | 1-Jan-88 | 0.5 |
N-Nitrosopiperidine | cancer | SQE | 100-75-4 | 1-Jan-88 | 0.07 |
N-Nitrosopyrrolidine | cancer | SQE | 930-55-2 | 1-Oct-87 | 0.3 |
N-Nitrososarcosine | cancer | SQE | 13256-22-9 | 1-Jan-88 | |
o-Nitrotoluene | cancer | AB | 88-72-2 | 15-May-98 | |
Nitrous oxide [Basis for listing changed effective November 8, 2013] | developmental, female | AB | 10024-97-2 | 1-Aug-08 | |
Norethisterone (Norethindrone) | cancer | LC | 68-22-4 | 1-Oct-89 | |
Norethisterone (Norethindrone) | developmental | FR | 68-22-4 | 1-Apr-90 | |
Norethisterone acetate (Norethindrone acetate) | developmental | FR | 51-98-9 | 1-Oct-91 | |
Norethisterone (Norethindrone) /Ethinyl estradiol | developmental | FR | 68-22-4/ 57-63-6 | 1-Apr-90 | |
Norethisterone (Norethindrone) /Mestranol | developmental | FR | 68-22-4/ 72-33-3 | 1-Apr-90 | |
Norethynodrel | cancer | AB | 68-23-5 | 27-Feb-01 | |
Norgestrel | developmental | FR | 6533-00-2 | 1-Apr-90 | |
Ochratoxin A | cancer | AB | 303-47-9 | 1-Jul-90 | |
Oil Orange SS | cancer | SQE | 2646-17-5 | 1-Apr-88 | |
Oral contraceptives, combined | cancer | LC | --- | 1-Oct-89 | |
Oral contraceptives, sequential | cancer | LC | --- | 1-Oct-89 | |
Oryzalin | cancer | AB | 19044-88-3 | 12-Sep-08 | |
Oxadiazon | cancer | SQE | 19666-30-9 | 1-Jul-91 | |
Oxadiazon | developmental | AB | 19666-30-9 | 15-May-98 | |
Oxazepam | cancer | AB | 604-75-1 | 1-Oct-94 | |
Oxazepam | developmental | FR | 604-75-1 | 1-Oct-92 | |
p,p'-Oxybis(benzenesulfonyl hydrazide) Delisted December 13, 2013 [Click here for the basis for delisting] | |||||
Oxydemeton methyl | female, male | AB | 301-12-2 | 6-Nov-98 | |
Oxymetholone | cancer | SQE | 434-07-1 | 1-Jan-88 | |
Oxymetholone | developmental | FR | 434-07-1 | 1-May-97 | |
Oxytetracycline (internal use) | developmental | FR | 79-57-2 | 1-Jan-91 | |
Oxytetracycline hydrochloride (internal use) | developmental | FR | 2058-46-0 | 1-Oct-91 | |
Oxythioquinox (Chinomethionat) | cancer | AB | 2439-01-2 | 20-Aug-99 | |
Oxythioquinox (Chinomethionat) | developmental | AB | 2439-01-2 | 6-Nov-98 | |
Paclitaxel | developmental, female, male | FR | 33069-62-4 | 26-Aug-97 | |
Palygorskite fibers (> 5mm in length) | cancer | AB | 12174-11-7 | 28-Dec-99 | |
Panfuran S | cancer | SQE | 794-93-4 | 1-Jan-88 | |
Paramethadione | developmental | FR | 115-67-3 | 1-Jul-90 | |
Penicillamine | developmental | FR | 52-67-5 | 1-Jan-91 | |
Pentachlorophenol | cancer | AB | 87-86-5 | 1-Jan-90 | 40 |
Pentobarbital sodium | developmental | FR | 57-33-0 | 1-Jul-90 | |
Pentosan polysulfate sodium | cancer | LC | --- | 18-Apr-14 | |
Pentostatin | developmental | FR | 53910-25-1 | 1-Sep-96 | |
Phenacemide | developmental | FR | 63-98-9 | 1-Jul-90 | |
Phenacetin | cancer | LC | 62-44-2 | 1-Oct-89 | 300 |
Phenazopyridine | cancer | SQE | 94-78-0 | 1-Jan-88 | 4 |
Phenazopyridine hydrochloride | cancer | SQE | 136-40-3 | 1-Jan-88 | 5 |
Phenesterin | cancer | SQE | 3546-10-9 | 1-Jul-89 | 0.005 |
Phenobarbital | cancer | AB | 50-06-6 | 1-Jan-90 | 2 |
Phenolphthalein | cancer | AB | 77-09-8 | 15-May-98 | |
Phenoxybenzamine | cancer | SQE | 59-96-1 | 1-Apr-88 | 0.2 |
Phenoxybenzamine hydrochloride | cancer | SQE | 63-92-3 | 1-Apr-88 | 0.3 |
Phenprocoumon | developmental | FR | 435-97-2 | 1-Oct-92 | |
o-Phenylenediamine and its salts | cancer | AB | 95-54-5 | 15-May-98 | |
o-Phenylenediamine | 26 | ||||
o-Phenylenediamine dihydochloride | 44 | ||||
Phenyl glycidyl ether | cancer | AB | 122-60-1 | 1-Oct-90 | 5 |
LC | |||||
Delisted April 4, 2014 [Click here | |||||
for the basis for delisting] | |||||
Phenylhydrazine and its salts | cancer | AB | --- | 1-Jul-92 | |
Phenylhydrazine | 1 | ||||
Phenylhydrazine hydrochloride | 1.4 | ||||
o-Phenylphenate, sodium | cancer | AB | 132-27-4 | 1-Jan-90 | 200 |
o-Phenylphenol | cancer | AB | 90-43-7 | 4-Aug-00 | |
Phenylphosphine [Basis for listing changed effective June 6, 2014] |
|
638-21-1 | 7-Aug-09 | ||
PhiP(2-Amino-1-methyl-6-phenylimidazol[4,5-b]pyridine) | cancer | AB | 105650-23-5 | 1-Oct-94 | |
Pimozide | developmental, female | FR | 2062-78-4 | 20-Aug-99 | |
Pioglitazone | cancer | LC | 111025-46-8 | 18-Apr-14 | |
Pipobroman | developmental | FR | 54-91-1 | 1-Jul-90 | |
Pirimicarb | cancer | AB | 23103-98-2 | 1-Jul-08 | |
Plicamycin | developmental | FR | 18378-89-7 | 1-Apr-90 | |
Polybrominated biphenyls | cancer | SQE | --- | 1-Jan-88 | 0.02 |
Polybrominated biphenyls | developmental | AB | --- | 1-Oct-94 | |
Polychlorinated biphenyls | cancer | LC | --- | 1-Oct-89 | 0.09 |
Polychlorinated biphenyls | developmental | SQE | --- | 1-Jan-91 | |
Polychlorinated biphenyls (containing 60 or more percent percent chlorine by molecular weight) | cancer | SQE | --- | 1-Jan-88 | |
Polychlorinated dibenzo-p-dioxins | cancer | FR | --- | 1-Oct-92 | |
Polychlorinated dibenzofurans | cancer | FR | --- | 1-Oct-92 | |
Polygeenan | cancer | SQE | 53973-98-1 | 1-Jan-88 | 1200 |
Ponceau MX | cancer | SQE | 3761-53-3 | 1-Apr-88 | 200 |
Ponceau 3R | cancer | SQE | 3564-09-8 | 1-Apr-88 | 40 |
Potassium bromate | cancer | AB | 7758-01-2 | 1-Jan-90 | 1 |
Potassium dimethyldithiocarbamate | developmental | AB | 128-03-0 | 30-Mar-99 | 720 |
Pravastatin sodium | developmental | FR | 81131-70-6 | 3-Mar-00 | |
Prednisolone sodium phosphate | developmental | FR | 125-02-0 | 20-Aug-99 | |
Primidone | cancer | AB | 125-33-7 | 20-Aug-99 | |
Procarbazine | cancer | SQE | 671-16-9 | 1-Jan-88 | 0.05 |
Procarbazine hydrochloride | cancer | SQE | 366-70-1 | 1-Jan-88 | 0.06 |
Procarbazine hydrochloride | developmental | FR | 366-70-1 | 1-Jul-90 | |
Procymidone | cancer | AB | 32809-16-8 | 1-Oct-94 | |
Progesterone | cancer | SQE | 57-83-0 | 1-Jan-88 | |
Pronamide | cancer | AB | 23950-58-5 | 1-May-96 | |
Propachlor | cancer | AB | 1918-16-7 | 27-Feb-01 | |
1,3-Propane sultone | cancer | SQE | 1120-71-4 | 1-Jan-88 | 0.3 |
Propargite | cancer | AB | 2312-35-8 | 1-Oct-94 | |
Propargite | developmental | AB | 2312-35-8 | 15-Jun-99 | |
beta-Propiolactone | cancer | SQE | 57-57-8 | 1-Jan-88 | 0.05 |
Propoxur | cancer | AB | 114-26-1 | 11-Aug-06 | |
Propylene glycol mono-t-butyl ether | cancer | AB | 57018-52-7 | 11-Jun-04 | |
Propylene oxide | cancer | SQE | 75-56-9 | 1-Oct-88 | |
Propylthiouracil | cancer | SQE | 51-52-5 | 1-Jan-88 | 0.7 |
Propylthiouracil | developmental | FR | 51-52-5 | 1-Jul-90 | |
Pulegone | cancer | LC | 89-82-7 | 18-Apr-14 | |
Pymetrozine | cancer | AB | 123312-89-0 | 22-Mar-11 | |
Pyridine | cancer | AB | 110-86-1 | 17-May-02 | |
Pyrimethamine | developmental | FR | 58-14-0 | 29-Jan-99 | |
Quazepam | developmental | FR | 36735-22-5 | 26-Aug-97 | |
Quinoline and its strong acid salts | cancer | SQE | --- | 24-Oct-97 | |
Quizalofop-ethyl | male | SQE | 76578-14-8 | 24-Dec-99 | 590 |
Radionuclides | cancer | SQE | --- | 1-Jul-89 | |
Reserpine | cancer | LC | 50-55-5 | 1-Oct-89 | 0.06 |
Residual (heavy) fuel oils | cancer | AB | --- | 1-Oct-90 | |
Resmethrin | cancer | AB | 10453-86-8 | 1-Jul-08 | |
Resmethrin | developmental | AB | 10453-86-8 | 6-Nov-98 | |
Retinol/retinyl esters, when in daily dosages in excess of 10,000 IU, or 3,000 retinol equivalents. (NOTE: Retinol/retinyl esters are required and essential for maintenance of normal reproductive function. The recommended daily level during pregnancy is 8,000 IU.) | developmental | SQE | --- | 1-Jul-89 | |
Ribavirin | developmental | FR | 36791-04-5 | 1-Apr-90 | |
Ribavirin | male | FR | 36791-04-5 | 27-Feb-01 | |
Riddelliine | cancer | LC | 23246-96-0 | 3-Dec-04 | |
Rifampin | developmental, female | FR | 13292-46-1 | 27-Feb-01 | |
Saccharin Delisted April 6, 2001 [Click here for the basis for delisting] | |||||
Saccharin, sodium Delisted January 17, 2003 [Click here for the basis for delisting] | |||||
Safrole | cancer | SQE | 94-59-7 | 1-Jan-88 | 3 |
Salted fish, Chinese-style | cancer | LC | --- | 29-Apr-11 | |
Secobarbital sodium | developmental | FR | 309-43-3 | 1-Oct-92 | |
Selenium sulfide | cancer | LC | 7446-34-6 | 1-Oct-89 | |
Sermorelin acetate | developmental | FR | --- | 20-Aug-99 | |
Shale-oils | cancer | AB | 68308-34-9 | 1-Apr-90 | |
Silica, crystalline (airborne particles of respirable size) | cancer | SQE | --- | 1-Oct-88 | |
Sodium dimethyldithiocarbamate | developmental | AB | 128-04-1 | 30-Mar-99 | 23 (oral) 58 (oral) as a 40% pesticidal formulation |
Sodium fluoroacetate | male | AB | 62-74-8 | 6-Nov-98 | |
Soots, tars, and mineral oils (untreated and mildly treated oils and used engine oils) | cancer | LC | --- | 27-Feb-87 | |
Spirodiclofen | cancer | AB | 148477-71-8 | 8-Oct-10 | |
Spironolactone | cancer | FR | 52-01-7 | 1-May-97 | |
Stanozolol | cancer | FR | 10418-03-8 | 1-May-97 | |
Sterigmatocystin | cancer | SQE | 10048-13-2 | 1-Apr-88 | 0.02 |
Streptomycin sulfate | developmental | 3810-74-0 | 1-Jan-91 | ||
Streptozocin (streptozotocin) | developmental, female, male | FR | 18883-66-4 | 20-Aug-99 | |
Streptozotocin (streptozocin) | cancer | SQE | 18883-66-4 | 1-Jan-88 | 0.006 |
Strong inorganic acid mists containing sulfuric acid | cancer | AB | --- | 14-Mar-03 | |
Styrene oxide | cancer | SQE | 96-09-3 | 1-Oct-88 | 4 |
Sulfallate | cancer | SQE | 95-06-7 | 1-Jan-88 | 4 |
Sulfasalazine (salicylazosulfapyridine) | cancer | AB | 599-79-1 | 15-May-98 | |
Sulfasalazine (salicylazosulfapyridine) | male | FR | 599-79-1 | 29-Jan-99 | |
Sulfur dioxidee | developmental | SQE | 7446-09-5 | 29-Jul-11 | 10000 |
Sulindac | developmental, female | FR | 38194-50-2 | 29-Jan-99 | |
Talc containing asbestiform fibers | cancer | AB | --- | 1-Apr-90 | |
Tamoxifen and its salts | cancer | SQE | 10540-29-1 | 1-Sep-96 | |
Tamoxifen citrate | developmental | FR | 54965-24-1 | 1-Jul-90 | |
Temazepam | developmental | FR | 846-50-4 | 1-Apr-90 | |
Teniposide | developmental | FR | 29767-20-2 | 1-Sep-96 | |
Terbacil | developmental | AB | 5902-51-2 | 18-May-99 | |
Terrazole | cancer | AB | 2593-15-9 | 1-Oct-94 | |
Testosterone and its esters | cancer | SQE | 58-22-0 | 1-Apr-88 | |
Testosterone cypionate | developmental | FR | 58-20-8 | 1-Oct-91 | |
Testosterone enanthate | developmental | FR | 315-37-7 | 1-Apr-90 | |
3,3',4,4'-Tetrachloroazobenzene | cancer | AB | 14047-09-7 | 24-Jul-12 | |
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) | cancer | SQE | 1746-01-6 | 1-Jan-88 | 0.000005 |
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) | developmental | AB | 1746-01-6 | 1-Apr-91 | |
1,1,1,2-Tetrachloroethane | cancer | LC | 630-20-6 | 13-Sep-13 | |
1,1,2,2-Tetrachloroethane | cancer | AB | 79-34-5 | 1-Jul-90 | 3 |
Tetrachloroethylene (Perchloroethylene) | cancer | SQE | 127-18-4 | 1-Apr-88 | 14 |
p-a,a,a-Tetrachlorotoluene | cancer | AB | 5216-25-1 | 1-Jan-90 | |
Tetracycline (internal use) | developmental | FR | 60-54-8 | 1-Oct-91 | |
Tetracyclines (internal use) | developmental | FR | --- | 1-Oct-92 | |
Tetracycline hydrochloride (internal use) | developmental | FR | 64-75-5 | 1-Jan-91 | |
Tetrafluoroethylene | cancer | AB | 116-14-3 | 1-May-97 | |
Tetranitromethane | cancer | AB | 509-14-8 | 1-Jul-90 | 0.059 |
Thalidomide | developmental | SQE | 50-35-1 | 1-Jul-87 | |
Thioacetamide | cancer | SQE | 62-55-5 | 1-Jan-88 | 0.1 |
4,4'-Thiodianiline | cancer | SQE | 139-65-1 | 1-Apr-88 | 0.05 |
Thiodicarb | cancer | AB | 59669-26-0 | 20-Aug-99 | |
Thioguanine | developmental | FR | 154-42-7 | 1-Jul-90 | |
Thiophanate methyl | female, male | AB | 23564-05-8 | 18-May-99 | 600 (oral) |
Thiouracil | cancer | AB | 141-90-2 | 11-Jun-04 | |
Thiourea | cancer | SQE | 62-56-6 | 1-Jan-88 | 10 |
Thorium dioxide | cancer | LC | 1314-20-1 | 27-Feb-87 | |
Titanium dioxide (airborne, unbound particles of respirable size) | cancer | LC | --- | 2-Sep-11 | |
Tobacco, oral use of smokeless products | cancer | SQE | --- | 1-Apr-88 | |
Tobacco smoke | cancer | SQE | --- | 1-Apr-88 | |
Tobacco smoke (primary) | developmental, female, male | SQE | --- | 1-Apr-88 | |
Tobramycin sulfate | developmental | FR | 49842-07-1 | 1-Jul-90 | |
Toluene | developmental | SQE | 108-88-3 | 1-Jan-91 | 7000c |
Toluene [Click here for the basis for the removal of female reproductive endpoint effective March 7, 2014] | |||||
Toluene diisocyanate | cancer | LC | 26471-62-5 | 1-Oct-89 | 20 |
o-Toluidine | cancer | SQE | 95-53-4 | 1-Jan-88 | 4 |
o-Toluidine hydrochloride | cancer | SQE | 636-21-5 | 1-Jan-88 | 5 |
para-Toluidine Delisted October 29, 1999 [Click here for the basis for delisting] | |||||
Toxaphene (Polychlorinated camphenes) | cancer | SQE | 8001-35-2 | 1-Jan-88 | 0.6 |
Toxins derived from Fusarium moniliforme (Fusarium verticillioides) | cancer | LC | --- | 7-Aug-09 | |
Treosulfan | cancer | LC | 299-75-2 | 27-Feb-87 | |
Triadimefon | developmental, female, male | AB | 43121-43-3 | 30-Mar-99 | |
Triamterene | cancer | LC | 396-01-0 | 18-Apr-14 | |
Triazolam | developmental | FR | 28911-01-5 | 1-Apr-90 | |
S,S,S-Tributyl phosphorotrithioate (Tribufos, DEF) | cancer | AB | 78-48-8 | 25-Feb-11 | |
Tributyltin methacrylate | developmental | AB | 2155-70-6 | 1-Dec-99 | |
Trichlormethine (Trimustine hydrochloride) | cancer | AB | 817-09-4 | 1-Jan-92 | |
Trichloroacetic acid | cancer | LC | 76-03-9 | 13-Sep-13 | |
Trichloroethylene | cancer | SQE | 79-01-6 | 1-Apr-88 | 14 (oral) 50 (inhalation) |
Trichloroethylene | developmental, male | AB | 79-01-6 | 31-Jan-14 | |
2,4,6-Trichlorophenol | cancer | SQE | 88-06-2 | 1-Jan-88 | 10 |
1,2,3-Trichloropropane | cancer | AB | 96-18-4 | 1-Oct-92 | |
Trientine hydrochloride | developmental | FR | 38260-01-4 | 27-Feb-01 | |
Triforine | developmental | AB | 26644-46-2 | 18-Jun-99 | |
1,3,5-Triglycidyl-s-triazinetrione Delisted December 13, 2013 [Click here for the basis for delisting] | |||||
Trilostane | developmental | FR | 13647-35-3 | 1-Apr-90 | |
Trimethadione | developmental | FR | 127-48-0 | 1-Jan-91 | |
2,4,5-Trimethylaniline and its strong acid salts | cancer | SQE | --- | 24-Oct-97 | |
Trimethyl phosphate | cancer | AB | 512-56-1 | 1-May-96 | 24 |
Trimetrexate glucuronate | developmental | FR | 82952-64-5 | 26-Aug-97 | |
2,4.6-Trinitrotoluene (TNT) | cancer | SQE | 118-96-7 | 19-Dec-08 | 8.2 |
Triphenyltin hydroxide | cancer | AB | 76-87-9 | 1-Jul-92 | |
Triphenyltin hydroxide | developmental | AB | 76-87-9 | 18-Mar-02 | |
Tris(aziridinyl)-p-benzoquinone (Triaziquone) Delisted December 8, 2006 [Click here for the basis for delisting] | |||||
Tris(1-aziridinyl)phosphine sulfide (Thiotepa) | cancer | SQE | 52-24-4 | 1-Jan-88 | 0.06 |
Tris(2-chloroethyl) phosphate | cancer | AB | 115-96-8 | 1-Apr-92 | |
Tris(2,3-dibromopropyl)phosphate | cancer | SQE | 126-72-7 | 1-Jan-88 | 0.3 |
Tris(1,3-dichloro-2-propyl) phosphate (TDCPP) | cancer | SQE | 13674-87-8 | 28-Oct-11 | 5.4 |
Trp-P-1 (Tryptophan-P-1) | cancer | SQE | 62450-06-0 | 1-Apr-88 | 0.03 |
Trp-P-2 (Tryptophan-P-2) | cancer | SQE | 62450-07-1 | 1-Apr-88 | 0.2 |
Trypan blue (commercial grade) | cancer | LC | 72-57-1 | 1-Oct-89 | |
Unleaded gasoline (wholly vaporized) | cancer | SQE | --- | 1-Apr-88 | |
Uracil mustard | cancer | SQE | 66-75-1 | 1-Apr-88 | |
Uracil mustard | developmental, female, male | FR | 66-75-1 | 1-Jan-92 | |
Urethane (Ethyl carbamate) | cancer | SQE | 51-79-6 | 1-Jan-88 | 0.7 |
Urethane (Ethyl carbamate) | developmental | AB | 51-79-6 | 1-Oct-94 | |
Urofollitropin | developmental | FR | 97048-13-0 | 1-Apr-90 | |
Valproate (Valproic acid) | developmental | SQE | 99-66-1 | 1-Jul-87 | |
Vanadium pentoxide (orthorhombic crystalline form) | cancer | AB | 1314-62-1 | 11-Feb-05 | |
Vinblastine sulfate | developmental | FR | 143-67-9 | 1-Jul-90 | |
Vinclozolin | cancer | AB | 50471-44-8 | 20-Aug-99 | |
Vinclozolin | developmental | AB | 50471-44-8 | 15-May-98 | |
Vincristine sulfate | developmental | FR | 2068-78-2 | 1-Jul-90 | |
Vinyl bromide | cancer | SQE | 593-60-2 | 1-Oct-88 | |
Vinyl chloride | cancer | LC | 75-01-4 | 27-Feb-87 | 3 |
4-Vinylcyclohexene | cancer | AB | 100-40-3 | 1-May-96 | |
4-Vinylcyclohexene [Click here for the basis for the removal of male reproductive endpoint, effective December 20, 2013 ] | female, |
SQE | 100-40--3 | 7-Aug-09 | |
4-Vinyl-1-cyclohexene diepoxide (Vinyl cyclohexenedioxide) | cancer | AB | 106-87-6 | 1-Jul-90 | |
Vinyl cyclohexene dioxide (4-Vinyl-1-cyclohexene diepoxide) [Click here for the basis for the removal of male reproductive endpoint, effective December 20, 2013] | female, |
SQE | 106-87-6 | 1-Aug-08 | |
Vinyl fluoride | cancer | AB | 75-02-5 | 1-May-97 | |
Vinyl trichloride (1,1,2-Trichloroethane) | cancer | AB | 79-00-5 | 1-Oct-90 | 10 |
Warfarin | developmental | SQE | 81-81-2 | 1-Jul-87 | |
Wood dust | cancer | LC | --- | 18-Dec-09 | |
2,6-Xylidine (2,6-Dimethylaniline) | cancer | AB | 87-62-7 | 1-Jan-91 | 110 |
Zalcitabine | cancer | LC | 7481-89-2 | 7-Aug-09 | |
Zidovudine (AZT) | cancer | LC | 30516-87-1 | 18-Dec-09 | |
Zileuton | cancer, developmental, female | FR | 111406-87-2 | 22-Dec-00 | |
Zineb Delisted October 29, 1999 [Click here for the basis for delisting] |
"RAM" Prefix Code
To provide lightweight strength and corrosion resistance, RAM is made of marine grade aluminum with a black powder coated finish, stainless steel hardware and rubber balls. The standard mount bases include a yoke mount, round base, rubber suction cup and U-bolt handlebar for attaching electronic and GPS devices. Other configurations can be considered for laptop systems in vehicles and marine uses.
Recognized and accepted by the U.S. Patent Office, RAM is the only universal ball-and-socket system that holds tremendous amounts of weight in high vibration applications for military, commercial and private use.
"RAP" Prefix Code
Many of these parts are available in composite, mount part number has the prefix code RAP. The composite components include both single and double socket arm assemblies with the same patented rubber ball and socket technology. The octagon button system works with the Quick Snap Belt Clip Holder, Quick Snap Surface. The new Snap Flex Link System is a male to female snap together configuration that has screws to tension the joint. The RAM Rail Mounts for handle bars and railings with a 1" rubber ball and or diamond base for adaptation to any other diamond base system. Then again, the possible mounting solutions are endless, affordable and backed by the NPI Lifetime Warranty.